Tuesday 23 April, 2024
Generic Medicine Funding: A step forward? Maybe, but bigger changes needed!
Leukaemia & Blood Cancer New Zealand welcomes the proposal to expand access to generic lenalidomide and pomalidomide. This decision will bring New Zealanders one step closer to the established standard of care and will enable New Zealand haematologists to practice in closer alignment with internationally recognised clinical treatment pathways...
Read more